Invesco’s Omega Protein OME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-33,624
| Closed | -$560K | – | 3700 |
|
|
2017
Q3 | $560K | Sell |
33,624
-193,251
| -85% | -$3.14M | ﹤0.01% | 3271 |
|
|
2017
Q2 | $4.06M | Sell |
226,875
-43,725
| -16% | -$817K | ﹤0.01% | 2092 |
|
|
2017
Q1 | $5.42M | Buy |
270,600
+10,009
| +4% | +$233K | ﹤0.01% | 1932 |
|
|
2016
Q4 | $6.53M | Sell |
260,591
-17,735
| -6% | -$419K | ﹤0.01% | 1803 |
|
|
2016
Q3 | $6.5M | Buy |
278,326
+72,095
| +35% | +$1.69M | ﹤0.01% | 1803 |
|
|
2016
Q2 | $4.12M | Sell |
206,231
-50,151
| -20% | -$936K | ﹤0.01% | 2054 |
|
|
2016
Q1 | $4.34M | Buy |
256,382
+20,738
| +9% | +$425K | ﹤0.01% | 1970 |
|
|
2015
Q4 | $5.23M | Buy |
235,644
+104,133
| +79% | +$2.17M | ﹤0.01% | 1878 |
|
|
2015
Q3 | $2.23M | Sell |
131,511
-801
| -0.6% | -$12.5K | ﹤0.01% | 2426 |
|
|
2015
Q2 | $1.82M | Buy |
132,312
+34,968
| +36% | +$465K | ﹤0.01% | 2694 |
|
|
2015
Q1 | $1.33M | Buy |
97,344
+10,495
| +12% | +$121K | ﹤0.01% | 2873 |
|
|
2014
Q4 | $917K | Sell |
86,849
-134,820
| -61% | -$1.6M | ﹤0.01% | 3016 |
|
|
2014
Q3 | $2.77M | Buy |
221,669
+158,377
| +250% | +$2.21M | ﹤0.01% | 2330 |
|
|
2014
Q2 | $866K | Sell |
63,292
-324
| -0.5% | -$4.24K | ﹤0.01% | 3095 |
|
|
2014
Q1 | $768K | Buy |
63,616
+1,909
| +3% | +$21.9K | ﹤0.01% | 3186 |
|
|
2013
Q4 | $758K | Buy |
61,707
+943
| +2% | +$11.1K | ﹤0.01% | 3248 |
|
|
2013
Q3 | $618K | Buy |
60,764
+6,625
| +12% | +$61.9K | ﹤0.01% | 3294 |
|
|
2013
Q2 | $486K | Buy |
+54,139
| New | +$545K | ﹤0.01% | 3291 |
|
Invesco's OME Position: Q4 2017 in Review
Invesco sold out of Omega Protein (OME) in Q4 2017, closing a stake of 33,624 shares — an estimated $560K sold.
Invesco first reported a position in OME in Q2 2013 and held it in 18 quarters. The position peaked at $6.53M in Q4 2016. 0 funds tracked by Wall St. Rank hold OME as of Q4 2017.
- Invesco reported no remaining Omega Protein position as of Q4 2017 after selling out during the quarter.
- Invesco sold 33,624 Omega Protein shares in Q4 2017, an estimated $560K.
- Invesco first reported a position in Omega Protein in Q2 2013 and held it in 18 quarters.
- Invesco's Omega Protein position peaked at $6.53M in Q4 2016.
- 0 funds tracked by Wall St. Rank held Omega Protein as of Q4 2017.
Based on Invesco's 13F filing for Q4 2017, filed 14 Feb 2018.